Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
3.250
-0.920 (-22.06%)
At close: Jun 23, 2025, 4:00 PM
2.990
-0.260 (-8.00%)
Pre-market: Jun 24, 2025, 5:58 AM EDT
APVO's stock price has decreased by -99.17% in the past year and price targets may not have had time to catch up.
Aptevo Therapeutics Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$5,920.00
Upside
+182,053.85%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Maintains $11,100 → $5,920 | Strong Buy | Maintains | $11,100 → $5,920 | +182,053.85% | Sep 23, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $2,246,640 → $651,200 | Buy | Maintains | $2,246,640 → $651,200 | +20,036,823.08% | May 13, 2022 |
| Roth Capital | Roth Capital | Strong Buy Maintains $2,083,840 → $1,628,000 | Strong Buy | Maintains | $2,083,840 → $1,628,000 | +50,092,207.69% | May 28, 2021 |
| Piper Sandler | Piper Sandler | Buy Maintains $1,041,920 → $2,246,640 | Buy | Maintains | $1,041,920 → $2,246,640 | +69,127,284.62% | Nov 11, 2020 |
| Roth Capital | Roth Capital | Strong Buy Initiates $5,470,080 | Strong Buy | Initiates | $5,470,080 | +168,310,053.85% | Apr 11, 2018 |
| Piper Sandler | Piper Sandler | Buy Initiates $3,190,880 | Buy | Initiates | $3,190,880 | +98,180,823.08% | Sep 9, 2016 |